Renin-angiotensin-aldosterone system blockers and cardiovascular outcomes: a meta-analysis of randomized clinical trials

---

Copy For Citation

Kizilirmak P., Uresin Y., Ozdemir O., Avci B. K., Tokgozoglu L., Ongen Z.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, vol.45, no.1, pp.49-66, 2017 (ESCI)

• Publication Type: Article / Article
• Volume: 45 Issue: 1
• Publication Date: 2017
• Doi Number: 10.5543/tkda.2016.78006
• Journal Name: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
• Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
• Page Numbers: pp.49-66
• Hacettepe University Affiliated: Yes

Abstract

Objective: Hypertension is the most prevalent modifiable risk factor for cardiovascular (CV) and cerebrovascular morbidity and mortality. This study aimed to assess the effects of renin-angiotensin-aldosterone system (RAAS) blockade on CV outcomes.